(Ethics and Communication) Illinois among states to settle with GlaxoSmithKline

This article discusses the key aspects of a vital settlement that was reached between GlaxoSmithKLine with 37 states for selling prescribed antidepressant from its Puerto Rico factory subsidiary. This particular settlement divided the money between District of Columbia and other states. The case was headed by Oregon and Illinois because they company violated the protection laws which resulted in a $750 million in criminal and civil settlements. The root cause was the fact that GlaxoSmithKline contaminated two main ingredients in the antidepressant in the ointment they produced. Although the two main ingredients: Kytril and Bactroban were not fully contaminated, the tablets possessed not a full dose of an active ingredient which did not satisfy the appropriate percentage of the substance